ChemomAb Competitors and Similar CompaniesClear all
Autolus's competitors and similar companies include Inozyme.
 Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Inozyme Inozyme is a biotechnology company that develops medicines to treat rare diseases of calcification. | |
Founding Date | Founding Date 2014 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations London, GB HQ London, GB | Locations Boston, US HQ Boston, US Boston, US |
Employees | Employees 647 | Employees 653% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 310 m |
Financial | ||
Net income | Net income ($287.5m) (FY, 2025) | Net income ($102m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 281.7m | Total funding raised $ 116m |
For sources of this data, please see the company profile
View Company Profiles
Inozyme
HQ
Boston, US
Employees
65↑ 3% increase
Inozyme is a biotechnology company that develops medicines to treat rare diseases of calcification.
View company